![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
July 10, 2025
A call to champion federally-funded cancer research, a discussion on limited radiation exposure from CT scans, and a TAILORx trial update
July 10, 2025
This clinical trial aims to improve survival for high-risk patients by adding a targeted therapy to standard post-surgery immunotherapy
July 10, 2025
In Sarcoma Cancer Awareness Month, we highlight a clinical trial for patients with this rare cancer, which has had few treatment advances
July 10, 2025
The latest clinical trial findings in breast, lung, nose/sinus, and throat cancers, as well as melanoma and cancer survivorship
July 10, 2025
Timely information about research presented at medical meetings, recognition of research leaders, and more
June 11, 2025
Dr. Grivas is honored as an international key opinion thought leader who has made outstanding contributions to genitourinary cancer research, clinical practice, leadership, teaching and mentorship, and community outreach
April 24, 2025
The changes broaden eligibility for this cancer care delivery study, which aims to improve medication adherence for patients with breast cancer
April 24, 2025
These two trials are open and enrolling adolescent and young adult survivors and patients with cancer
April 24, 2025
April 24, 2025
Summaries and links to timely information about research results presented at medical meetings, recognition of research leaders, and more
March 21, 2025
The changes significantly broaden eligibility and clarify key details in this phase 3 trial exploring whether adding radiation therapy to standard immunotherapy will improve survival in patients with stable disease after initial treatment
February 19, 2025
This is the first randomized phase 3 study to evaluate autologous stem cell transplantation in patients with this rare and aggressive form of non-Hodgkin lymphoma